Today we were humbled and amazed to see Bill Gates demo our work on mSpray, and describe it as pioneering! mSpray is a tool we developed with Akros in Zambia. With mSpray, we’ve shown that we can reduce malaria by 22% — that’s a 15% increase over traditional indoor residual spraying (IRS) programs. Using these same surveillance strategies we believe we can have a major impact with child immunization.
Find this video on social media:
If you are interested in exploring these opportunities with us, we’d love to hear from you email@example.com